Publication | Closed Access

Phillyrin attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1/AMP-activated protein kinase-dependent signalling

Metabolic SyndromeSignal TransductionBiochemistryMedicineLiver PhysiologyDiabetesMetabolic RegulationHepatotoxicityHuman Hepg2PharmacologyCell BiologyCell SignalingLipid SynthesisHealth Sciences